Sakura Bio Israeli Company
Sakura Bio has developed an off-the-shelf, naïve PBMC-derived allogeneic T-cell therapy to fight cancer — in particular, acute myeloid leukemia.
Health Tech & Life Sciences
Alternatives
No alternatives listed yet.
Suggest an Alternative
Office Locations
Jerusalem, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/sakura-bio
External links are provided for reference and verification purposes.